Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis

Abstract The association between thiazide use and fracture risk is still controversial. We conducted an updated meta-analysis on the association between thiazide use and fracture risk. We systematically searched PubMed, Embase, and Cochrane library databases for all types of human studies, including...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tesfaye Getachew Charkos, Yawen Liu, Lina Jin, Shuman Yang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cd3b0cb0624e49b898929b830ab61cb9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cd3b0cb0624e49b898929b830ab61cb9
record_format dspace
spelling oai:doaj.org-article:cd3b0cb0624e49b898929b830ab61cb92021-12-02T13:35:03ZThiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis10.1038/s41598-019-56108-42045-2322https://doaj.org/article/cd3b0cb0624e49b898929b830ab61cb92019-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-56108-4https://doaj.org/toc/2045-2322Abstract The association between thiazide use and fracture risk is still controversial. We conducted an updated meta-analysis on the association between thiazide use and fracture risk. We systematically searched PubMed, Embase, and Cochrane library databases for all types of human studies, including observational and experimental studies that were published up until July 2019. We also manually searched the reference lists of relevant studies. The pooled relative risks (RRs) with 95% credible interval (CrI) were calculated using a Bayesian hierarchical random effect model. A total of 19 case-control (N = 496,568 subjects) and 21 cohort studies (N = 4,418,602 subjects) were included in this meta-analysis. The pooled RR for fractures associated with thiazide use was 0.87 (95% CrI: 0.70–0.99) in case-control and 0.95 (95% CrI: 0.85–1.08) in cohort studies. The probabilities that thiazide use reduces any fracture risk by more than 0% were 93% in case-control studies and 72% in cohort studies. Significant heterogeneity was found for both case-control (p < 0.001, I2 = 75%) and cohort studies (p < 0.001, I2 = 97.2%). Thiazide use was associated with reduced fracture risk in case-control studies, but not in cohort studies. The associations demonstrated in case-control studies might be driven by inherent biases, such as selection bias and recall bias. Thus, thiazide use may not be a protective factor for fractures.Tesfaye Getachew CharkosYawen LiuLina JinShuman YangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-7 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tesfaye Getachew Charkos
Yawen Liu
Lina Jin
Shuman Yang
Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis
description Abstract The association between thiazide use and fracture risk is still controversial. We conducted an updated meta-analysis on the association between thiazide use and fracture risk. We systematically searched PubMed, Embase, and Cochrane library databases for all types of human studies, including observational and experimental studies that were published up until July 2019. We also manually searched the reference lists of relevant studies. The pooled relative risks (RRs) with 95% credible interval (CrI) were calculated using a Bayesian hierarchical random effect model. A total of 19 case-control (N = 496,568 subjects) and 21 cohort studies (N = 4,418,602 subjects) were included in this meta-analysis. The pooled RR for fractures associated with thiazide use was 0.87 (95% CrI: 0.70–0.99) in case-control and 0.95 (95% CrI: 0.85–1.08) in cohort studies. The probabilities that thiazide use reduces any fracture risk by more than 0% were 93% in case-control studies and 72% in cohort studies. Significant heterogeneity was found for both case-control (p < 0.001, I2 = 75%) and cohort studies (p < 0.001, I2 = 97.2%). Thiazide use was associated with reduced fracture risk in case-control studies, but not in cohort studies. The associations demonstrated in case-control studies might be driven by inherent biases, such as selection bias and recall bias. Thus, thiazide use may not be a protective factor for fractures.
format article
author Tesfaye Getachew Charkos
Yawen Liu
Lina Jin
Shuman Yang
author_facet Tesfaye Getachew Charkos
Yawen Liu
Lina Jin
Shuman Yang
author_sort Tesfaye Getachew Charkos
title Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis
title_short Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis
title_full Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis
title_fullStr Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis
title_full_unstemmed Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis
title_sort thiazide use and fracture risk: an updated bayesian meta-analysis
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/cd3b0cb0624e49b898929b830ab61cb9
work_keys_str_mv AT tesfayegetachewcharkos thiazideuseandfractureriskanupdatedbayesianmetaanalysis
AT yawenliu thiazideuseandfractureriskanupdatedbayesianmetaanalysis
AT linajin thiazideuseandfractureriskanupdatedbayesianmetaanalysis
AT shumanyang thiazideuseandfractureriskanupdatedbayesianmetaanalysis
_version_ 1718392701448093696